Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Charleville-Mézières

4 clinical trials in Charleville-Mézières, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Charleville-Mézières at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Charleville-Mézières

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amiodarone Hydrochloride
  • Sponsor:Centre Hospitalier De Versailles
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Folic Acid
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Centre Hospitalier Bethune Beuvry

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Charleville-Mézières

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on out-of-hospital cardiac arrest management, specifically investigating prophylactic treatments for patients with shockable rhythm. Research aims to evaluate the effectiveness of amiodarone in preventing ventricular arrhythmia recurrence.

  • Cardiac Arrest Management
  • Arrhythmia Prevention
  • Emergency Cardiac Care

Research emphasizes reducing mortality rates and improving immediate post-arrest care outcomes.

02 Rheumatology Studies

Clinical investigations comparing treatment options for Giant Cell Arteritis, evaluating the efficacy of methotrexate versus tocilizumab in long-term disease management.

  • Vasculitis Treatment
  • Inflammatory Disease Management
  • Comparative Drug Studies

Research focuses on determining optimal therapeutic approaches for sustained disease control.

03 Autoimmune Disorders

Advanced research into Eosinophilic Granulomatosis with Polyangiitis treatment, examining mepolizumab-based regimens for their glucocorticoid-sparing potential in both newly diagnosed and relapsing cases.

  • EGPA Management
  • Steroid-Sparing Strategies
  • Vasculitis Care

Studies aim to optimize treatment protocols while reducing steroid dependency.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.